SCHEMBL2381676

SCHEMBL2381676

O=C1NCNC2C=CC=CC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432319 0.73
SCHEMBL7353352 0.68
SCHEMBL5445328 0.67
SCHEMBL984926 0.67
SCHEMBL1075470 0.65
SCHEMBL10157505 0.65
SCHEMBL13845917 0.64 BACE1 (0.47)
SCHEMBL67709 0.62
SCHEMBL4802180 0.61 ALDH1A1 (0.37)
SCHEMBL4619683 0.61 BACE1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2909184-B1 NOVEL COMPOUNDS WITH PROTECTIVE ACTIVITY AGAINST TOXINS WITH INTRACELLULAR ACTION MODE COMMISSARIAT ENERGIE ATOMIQUE (FR) 2021-03-31 EP disclosed
US-9880171-B2 iASPP phosphorylation and metastatic potential LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (CH) 2018-01-30 US disclosed
US-9675615-B2 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-06-13 US disclosed
US-9540356-B2 Compounds having a protective activity against toxins with intracellular activity COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-01-10 US disclosed
US-20160223562-A1 Method for Determining the Concentration of a Peptide JPT PEPTIDE TECHNOLOGIES GMBH (DE) 2016-08-04 US disclosed
US-20150291568-A1 NEW COMPOUNDS HAVING A PROTECTIVE ACTIVITY AGAINST TOXINS WITH INTRACELLULAR ACTIVITY COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-10-15 US disclosed
US-20150285810-A1 IASPP PHOSPHORYLATION AND METASTATIC POTENTIAL LUDWIG INSTITUTE FOR CANCER RESEARCH LTD 2015-10-08 US disclosed
US-20150250788-A1 2,3-DIHYDROQUINAZOLIN-4(1H)-ONE DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-09-10 US disclosed
EP-2909184-A1 NEW COMPOUNDS HAVING A PROTECTIVE ACTIVITY AGAINST TOXINS WITH INTRACELLULAR ACTIVITY Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2015-08-26 EP disclosed
EP-2908817-A1 2,3-DIHYDROQUINAZOLIN-4(1 H)-ONE DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2015-08-26 EP disclosed
EP-2722047-A1 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2014-04-23 EP disclosed
WO-2013131019-A1 IASPP PHOSPHORYLATION AND METASTATIC POTENTIAL LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) 2013-09-06 WO disclosed
US-20130095514-A1 Method for Determining the Concentration of a Peptide JPT PEPTIDE TECHNOLOGIES GMBH (DE) 2013-04-18 US disclosed
EP-2545384-A1 METHOD FOR DETERMINING THE CONCENTRATION OF A PEPTIDE JPT Peptide Technologies GmbH (DE) 2013-01-16 EP disclosed
WO-2011110341-A1 METHOD FOR DETERMINING THE CONCENTRATION OF A PEPTIDE JPT PEPTIDE TECHNOLOGIES GMBH (DE) 2011-09-15 WO disclosed
WO-2002083884-A2 IMMOBILIZING METHOD AND ARRANGEMENTS OF COMPOUNDS, WHICH ARE PRODUCED THEREWITH, ON A PLANAR SURFACE JERINI AG (DE) 2002-10-24 WO disclosed
EP-0610439-B1 PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS AMERICAN HOME PROD (US) 1999-12-15 EP disclosed
US-5234936-A Treating hypertension, congestive heart failure, hyperlipidemia and hypercholesterolemia AMERICAN HOME PRODUCTS CORPORATION (US) 1993-08-10 US disclosed
US-4431440-A 2-/4-METHYLPHENYL/-4-3H-QUINAZOLINES AS HERBICIDES AND PLANT GROWTH REGULATORS; CEREALS AMERICAN CYANAMID COMPANY (US) 1984-02-14 US disclosed
EP-0058822-A1 Method to alter or control the development and/or life cycle of various plant species AMERICAN CYANAMID COMPANY (US) 1982-09-01 EP disclosed